➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Colorcon
Merck
Mallinckrodt
Dow

Last Updated: November 23, 2020

DrugPatentWatch Database Preview

Litigation Details for MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. (S.D. Fla. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. (S.D. Fla. 2020)

Docket   Start Trial Date Filed 2020-01-15
Court District Court, S.D. Florida Date Terminated
Cause 15:0002 Antitrust Litigation Assigned To James Lawrence King
Jury Demand Plaintiff Referred To
Parties AKROS PHARMA, INC.; BRISTOL-MYERS SQUIBB COMPANY; E. R. SQUIBB & SONS, LLC; GILEAD HOLDINGS, LLC; GILEAD SCIENCES IRELAND UC; GILEAD SCIENCES, INC.; GILEAD SCIENCES, LLC; JANSSEN R&D IRELAND; JAPAN TOBACCO INTERNATIONAL USA, INC.; JAPAN TOBACCO, INC.; JOHNSON & JOHNSON, INC.; MSP RECOVERY CLAIMS, SERIES LLC
Patents 6,043,230; 6,642,245; 6,703,396; 7,390,791; 7,803,788; 8,754,065; 9,296,769
Attorneys Alan H. Rolnick; Andres Rivero; Charles Edward Whorton; David Lee DaPonte; Jorge Alejandro Mestre
Firms Rivero Mestre
Link to Docket External link to docket
Small Molecule Drugs cited in MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. (S.D. Fla. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-01-15 1 5,977,089; and 6,043,230 (the “TDF Patents”). Teva asserted that the TDF patents were invalid, unenforceable…listed patent(s) and/or the patent is invalid and unenforceable. Simply by listing the patents in the…ANDA applicant for patent infringement. If the brand manufacturer brings a patent infringement action…legitimate patent protection or ferret out invalid, unenforceable, or narrow drug patents. 4. …has applied for patents that claim the formulation of TAF with FTC. See, e.g., U.S. Patent Application External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Mallinckrodt
McKinsey
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.